The RFAs for the network renewal were published on September 20, 2022. Please find links below. The deadline for grant submissions is November 21, 2022.
· Site RFA at the following link: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-031.html
NN106 CYTO-C Prospective biomarker study results have been published in Neurooncology Advances.
Results of the NN103 study were cited in NeurologyLive.
The results of the NN103 Beat MG have been posted online at the American Academy of Neurology.
Congratulations to Dixie Ecklund, Director of Operations at the NeuroNEXT DCC, for being selected to join the Society for Clinical Trials Class of 2021 Fellows! Ecklund will be recognized as a new inductee at the virtual SCT annual meeting in May.
A NeuroNEXT Fellowship can help young neurology faculty develop their careers, as highlighted by Wake Forest University in an article about former NeuroNEXT Fellow and Clinical Trials Methodology Course (CTMC) alumnus Dr. Heidi Munger Clay (see link below).
We are pleased to announce that the NINDS Clinical Trials Methodology Course (CTMC) is accepting applications for the 2021 cohort. The overarching goal of the CTMC is to help investigators develop scientifically rigorous, yet practical clinical trial protocols. Our focus is on investigators who have not previously designed their own prospective, interventional clinical trials.
Course:
NeuroNEXT Leadership would like to thank everyone for another successful annual meeting! We were able to celebrate several milestones in our virtual format, including:
A message from the Executive Committee of the Clinical Trials Methodology Course (CTMC):
Due to the global COVID-19 (Coronavirus) pandemic and the number of uncertainties that accompany such a health crisis, the Clinical Trials Methodology Course (CTMC) Executive Committee has decided to postpone the Course until next year.
A message from Merit Cudkowicz and Christopher Coffey, March 18, 2020:
Dear NeuroNEXT PIs and Coordinators,
We would like to share some updates regarding NeuroNEXT Network response to the evolving COVID-19 crisis.
The Association of Clinical Research Professionals (ACRP) has selected NeuroNEXT Project Manager Joyce Moran
We are pleased to announce that the NINDS Clinical Trials Methodology Course (CTMC) is accepting applications for the 2020 cohort. The overarching goal of the CTMC is to help junior investigators develop scientifically rigorous, yet practical clinical trial protocols.
The INC Pilot/Feasibility Core is now accepting applications for Pilot Awards. The goal of the INC Pilot Awards is to support investigators wishing to perform single or multi-site projects that will advance the diagnosis, clinical trial readiness, management, and/or treatment of CMT. Both senior investigators wishing to expand their research into new directions and Junior INC investigators are encouraged to apply.
MGNet, an NIH-funded Rare Diseases Clinical Research Consortium (RDCRC) in partnership with the Myasthenia Gravis Foundation of America and Concur MG, is seeking proposals that address the clinical research field in Myasthenia Gravis.
The slide presentation from the 2019 NeuroNEXT Annual Meeting in Pittsburgh, PA October 28-29 are now available on the NeuroNEXT private website. They can be accessed under Network Materials > Annual Meetings. Thanks to everyone for a successful meeting!
We are very excited to announce the first ever NINDS podcast for trainees!
The 2019 Clinical Trials Methodology Course was held in Iowa City in July. See below for an informational video from the University of Iowa on how the course helps investigators design large scale neurological studies.
The AAN is collaborating with the Medical University of South Carolina (MUSC) to offer The TRANSCENDS (Training in Research for Academic Neurologists to Sustain Careers and Enhance the Numbers of Diverse Scholars) Scholars program. This program is funded by a NINDS R25. The TRANSCENDS program is designed to train promising early-career neurologists to conduct high-quality neurologic research and achieve a successful academic career.
Program Details
NeuroNEXT was well-represented at the 40th Annual Meeting of the Society for Clinical Trials (SCT) this week. The meeting - hosted in New Orleans, LA, May 19-22, 2019 - featured two invited sessions by NeuroNEXT personnel:
NIH is soliciting for Pain Research Centers to join a clinical trial network. NIH has mounted a major effort to improve pain management as a part of its response to the opioid crisis in America. One cornerstone of that effort is an phase 2 clinical trial network to test new, non-addictive pain therapies in well-phenotyped patients. This is part of a public-private partnership with academia, pharmaceutical companies, biotechnology and device companies.